Document Detail


Treatment of genital condylomata with topical 5-fluorouracil.
MedLine Citation:
PMID:  1647908     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Use of topical 5-FU is indicated for therapy-resistant condylomata and for extensive untreated vulvar condylomata. It may be the treatment of choice for extensive or therapy-resistant vaginal condylomata. Applications of 5-FU once weekly to the vagina and twice weekly to the vulva for 10 weeks appear to be as effective as continued regimens but are better tolerated. Perhaps the greatest value of 5-FU lies in periodic application for prevention of recurrences of condylomata removed by surgical methods.
Authors:
H B Krebs
Related Documents :
21533718 - Italian law "measures to guarantee the access to palliative and pain treatments": rebou...
15631528 - Current and future treatment options for nonexudative and exudative age-related macular...
3786278 - Antithrombotic therapy for cerebrovascular disease. prevention and treatment of stroke.
16227068 - New developments in antidotes.
24617868 - Bristol deaths inquiry gets go-ahead.
15669948 - Intrarace differences among black and white americans presenting for chronic pain manag...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Dermatologic clinics     Volume:  9     ISSN:  0733-8635     ISO Abbreviation:  Dermatol Clin     Publication Date:  1991 Apr 
Date Detail:
Created Date:  1991-08-05     Completed Date:  1991-08-05     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8300886     Medline TA:  Dermatol Clin     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  333-41     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, George Washington University Hospital, DC.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Topical
Anus Neoplasms / drug therapy
Combined Modality Therapy
Condylomata Acuminata / drug therapy*,  surgery
Female
Fluorouracil / administration & dosage*,  adverse effects,  therapeutic use
Genital Neoplasms, Female / drug therapy*,  surgery
Humans
Laser Therapy
Papillomaviridae*
Tumor Virus Infections / drug therapy*,  surgery
Urethral Neoplasms / drug therapy
Vaginal Neoplasms / drug therapy
Vulvar Neoplasms / drug therapy
Chemical
Reg. No./Substance:
51-21-8/Fluorouracil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sexually transmitted papillomaviral infection in men. An update.
Next Document:  Anogenital papillomavirus infection and neoplasia in immunodeficient women: an update.